A Long-term Safety Study of Infliximab (Remicade)

ClinicalTrials.gov ID: NCT00261976

Public ClinicalTrials.gov record NCT00261976. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 23, 2026, 1:48 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Long-term Safety Follow-up of REMICADE (RESULTS)

Study identification

NCT ID: NCT00261976
Recruitment status: Completed
Study type: Observational
Phase: Not listed
Lead sponsor: Centocor, Inc.; Industry
Enrollment: 2,971 participants

Conditions and interventions

Conditions

Interventions

Infliximab (Remicade) Drug

Drug

Eligibility (public fields only)

Age range: Not listed
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jan 31, 2002
Primary completion: Feb 29, 2012
Completion: Feb 29, 2012
Last update posted: Mar 17, 2014

2002 – 2012

United States locations

U.S. sites: 100
U.S. states: 37
U.S. cities: 100

Facility	City	State	ZIP	Site status
Not listed	Birmingham	Alabama	—	—
Not listed	Huntsville	Alabama	—	—
Not listed	Montgomery	Alabama	—	—
Not listed	Paradise Valley	Arizona	—	—
Not listed	Phoenix	Arizona	—	—
Not listed	Tucson	Arizona	—	—
Not listed	Little Rock	Arkansas	—	—
Not listed	Anaheim	California	—	—
Not listed	Fresno	California	—	—
Not listed	Irvine	California	—	—
Not listed	Los Angeles	California	—	—
Not listed	Madera	California	—	—
Not listed	Orange	California	—	—
Not listed	Pasadena	California	—	—
Not listed	Rancho Mirage	California	—	—
Not listed	San Diego	California	—	—
Not listed	Santa Monica	California	—	—
Not listed	Stanford	California	—	—
Not listed	Torrance	California	—	—
Not listed	Denver	Colorado	—	—
Not listed	Hamden	Connecticut	—	—
Not listed	Hartford	Connecticut	—	—
Not listed	New Haven	Connecticut	—	—
Not listed	Waterbury	Connecticut	—	—
Not listed	Aventura	Florida	—	—
Not listed	Largo	Florida	—	—
Not listed	Ocala	Florida	—	—
Not listed	Orlando	Florida	—	—
Not listed	Palm Harbor	Florida	—	—
Not listed	Sarasota	Florida	—	—
Not listed	Tampa	Florida	—	—
Not listed	Alpharetta	Georgia	—	—
Not listed	Atlanta	Georgia	—	—
Not listed	Marietta	Georgia	—	—
Not listed	Coeur d'Alene	Idaho	—	—
Not listed	Chicago	Illinois	—	—
Not listed	Evanston	Illinois	—	—
Not listed	Gurnee	Illinois	—	—
Not listed	Maywood	Illinois	—	—
Not listed	Normal	Illinois	—	—
Not listed	Rockford	Illinois	—	—
Not listed	Springfield	Illinois	—	—
Not listed	Indianapolis	Indiana	—	—
Not listed	Iowa City	Iowa	—	—
Not listed	Overland Park	Kansas	—	—
Not listed	Wichita	Kansas	—	—
Not listed	Louisville	Kentucky	—	—
Not listed	Portland	Maine	—	—
Not listed	Baltimore	Maryland	—	—
Not listed	Greenbelt	Maryland	—	—
Not listed	Wheaton	Maryland	—	—
Not listed	Andover	Massachusetts	—	—
Not listed	Boston	Massachusetts	—	—
Not listed	Worcester	Massachusetts	—	—
Not listed	Ann Arbor	Michigan	—	—
Not listed	Detroti	Michigan	—	—
Not listed	East Lansing	Michigan	—	—
Not listed	Grand Rapids	Michigan	—	—
Not listed	Edina	Minnesota	—	—
Not listed	Fridley	Minnesota	—	—
Not listed	Jackson	Mississippi	—	—
Not listed	St Louis	Missouri	—	—
Not listed	Lincoln	Nebraska	—	—
Not listed	Reno	Nevada	—	—
Not listed	Voorhees Township	New Jersey	—	—
Not listed	Manhasset	New York	—	—
Not listed	New York	New York	—	—
Not listed	Rochester	New York	—	—
Not listed	Charlotte	North Carolina	—	—
Not listed	Durham	North Carolina	—	—
Not listed	Raleigh	North Carolina	—	—
Not listed	Wilmington	North Carolina	—	—
Not listed	Winston-Salem	North Carolina	—	—
Not listed	Akron	Ohio	—	—
Not listed	Cincinnati	Ohio	—	—
Not listed	Cleveland	Ohio	—	—
Not listed	Columbus	Ohio	—	—
Not listed	Oklahoma City	Oklahoma	—	—
Not listed	Lake Oswego	Oregon	—	—
Not listed	Portland	Oregon	—	—
Not listed	Bethlehem	Pennsylvania	—	—
Not listed	Lancaster	Pennsylvania	—	—
Not listed	Norristown	Pennsylvania	—	—
Not listed	Philadelphia Pennsylvan	Pennsylvania	—	—
Not listed	West Reading	Pennsylvania	—	—
Not listed	Willow Grove	Pennsylvania	—	—
Not listed	North Charleston	South Carolina	—	—
Not listed	Goodlettsville	Tennessee	—	—
Not listed	Nashville	Tennessee	—	—
Not listed	Dallas	Texas	—	—
Not listed	Houston	Texas	—	—
Not listed	Lubbock	Texas	—	—
Not listed	San Antonio	Texas	—	—
Not listed	Burlington	Vermont	—	—
Not listed	Salem	Virginia	—	—
Not listed	Bellevue	Washington	—	—
Not listed	Kirkland	Washington	—	—
Not listed	Seattle	Washington	—	—
Not listed	Spokane	Washington	—	—
Not listed	Milwaukee	Wisconsin	—	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 105 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00261976, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Mar 17, 2014 · Synced Jul 23, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00261976 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →